Location Overall pooled mean CLABSI Pooled mean CLABSI—permanent central line days Pooled mean CLABSI—temporary central line days Adult general medical/surgical inpatient 0.8 NA NA Adult medical/surgical ICU 0.8–1.1a NA NA…
© Springer International Publishing AG 2017Christopher E. Dandoy, Joanne M. Hilden, Amy L. Billett and Brigitta U. Mueller (eds.)Patient Safety and Quality in Pediatric Hematology/Oncology and Stem Cell Transplantation10.1007/978-3-319-53790-0_20 20. Quality Improvement and Patient Safety Resources Christopher E. Dandoy1 ,…
Research investigation Quality improvement Purpose To develop or contribute to generalizable knowledge Designed to implement knowledge, assess a process or program as judged by established/accepted standards Motivation for the…
Fig. 4.1 QI team members should include all members throughout the spectrum of the care process and allow for facile communication between all members. *Additional staff: advanced practice providers, pharmacists,…
Fatigue Lack of sleep Illness Drugs or alcohol Boredom, frustration Cognitive shortcuts Fear Stress Shift of work Reliance on memory Reliance on vigilance Interruptions and distractions Noise Heat Clutter Motion…
Safe Avoiding injuries to patients from the care that is intended to help them Effective Providing services based on scientific knowledge to all who could benefit and refraining from providing…
and Muşturay Karçaaltıncaba1 (1) Department of Radiology, Hacettepe University, Ankara, Turkey Muşturay Karçaaltıncaba Email: musturayk@yahoo.com Abstract The use of radiological imaging in urological cancers is increasing with improvements in imaging…
Fig. 12.1 Fascial coverings (curved arrow) over vasa deferentia (straight arrow) are released Fig. 12.2 Vas deferens and seminal vesicle being retracted (straight arrow) to develop the plane of dissection…
Fig. 16.1 Axial apparent diffusion coefficient map of a corresponding patient demonstrating prostate tumor at left peripheral zone Conventional 18-fluorodeoxyglucose (FDG) PET-CT has been widely used for various tumors [15–19];…
Low risk Intermediate risk High risk Clinical T1–T2a and Gleason <7 and PSA <10 ng/mL Clinical T2b or Gleason 7 or PSA 10–20 ng/mL Clinical T2c, T3a-b or Gleason 8–10 or PSA > 20 ng/mL…
